Epidemiology and characteristics of repeat adverse drug reactions and associated clinical outcomes in older adults: a systematic review and meta-analysis

PURPOSE: To systematically review and synthesise evidence on the incidence, characteristics, risk factors, and clinical outcomes of repeat adverse drug reactions (ADRs) in older adults. METHODS: A comprehensive search of four major databases was conducted. Studies reporting data on both index (initial) and repeat ADRs in populations with a mean or median age ≥ 60 years were included. A repeat ADR was defined as the occurrence of the same or a different ADR following an index ADR in the same individual. A meta-analysis estimated the pooled incidence rate (IR) of at least one repeat ADR-related hospitalisation. The protocol was registered in PROSPERO (CRD420251086319). RESULTS: = 82.7%). Three studies found that the same drugs or drug classes were implicated in both index and repeat ADR-related hospitalisations in 41.7 to 60% of cases. In-hospital mortality among patients with repeat ADR-related hospitalisations ranged from 0 to 68.1% (3 studies). CONCLUSION: Repeat ADRs and related hospitalisations pose a non-trivial risk in older adults and often involve the same drugs. Future research should evaluate system-level strategies to reduce preventable repeat events.

Authors

Institutions

Publication Details

Journal
European Geriatric Medicine
Published
2026-05-09
DOI
https://doi.org/10.1007/s41999-026-01501-2
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epidemiology and characteristics of repeat adverse drug reactions and associated clinical outcomes in older adults: a systematic review and meta-analysis

Woldesellassie M. Bezabhe, Behailu Terefe Tesfaye, Olive M. Schmid, Gregory M. Peterson et al.
European Geriatric Medicine
Pharmacovigilance and Adverse Drug Reactions
article

Epidemiology and characteristics of repeat adverse drug reactions and associated clinical outcomes in older adults: a systematic review and meta-analysis

Woldesellassie M. Bezabhe, Behailu Terefe Tesfaye, Olive M. Schmid, Gregory M. Peterson, Mohammed S. Salahudeen
article en

Abstract

PURPOSE: To systematically review and synthesise evidence on the incidence, characteristics, risk factors, and clinical outcomes of repeat adverse drug reactions (ADRs) in older adults. METHODS: A comprehensive search of four major databases was conducted. Studies reporting data on both index (initial) and repeat ADRs in populations with a mean or median age ≥ 60 years were included. A repeat ADR was defined as the occurrence of the same or a different ADR following an index ADR in the same individual. A meta-analysis estimated the pooled incidence rate (IR) of at least one repeat ADR-related hospitalisation. The protocol was registered in PROSPERO (CRD420251086319). RESULTS: = 82.7%). Three studies found that the same drugs or drug classes were implicated in both index and repeat ADR-related hospitalisations in 41.7 to 60% of cases. In-hospital mortality among patients with repeat ADR-related hospitalisations ranged from 0 to 68.1% (3 studies). CONCLUSION: Repeat ADRs and related hospitalisations pose a non-trivial risk in older adults and often involve the same drugs. Future research should evaluate system-level strategies to reduce preventable repeat events.

European Geriatric Medicine
University of Tasmania (AU)
University of Tasmania
Good health and well-being
Openalex Percentile: Top 6%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.